The NIIMBL leadership along with colleagues from the government and the biopharma industry authored a recent publication in Biotechnology & Bioengineering describing NIIMBL’s ambitious 10-year collaborative program to invent, design, demonstrate, and support the commercialization of integrated biopharmaceutical manufacturing technology intended to transform the industry.
Download information about the NIIMBL-led joint publication on end-to-end process intensification program.